Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.
Targhetta
C
C
Struttura Complessa della Disciplina di Ematologia e Centro Trapianti Cellule Staminali Emopoietiche. Ospedale Oncologico di Riferimento Regionale "Armando Businco", Cagliari, Italy.
Cabras
M G
MG
Angelucci
E
E
D000998:Antiviral Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007167:Immunotherapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000276:immunology*; D012307:Risk Factors
D000998:Antiviral Agents